Anita M. Preininger

Anita M. Preininger

Auto-generated profile, based on publicly available information

Anita M. Preininger

IBM Watson Health, Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in Endocrine Reviews
Verified
Journal Article
Closed access
TCTheresa M. Cabrera-Vera
Theresa M. Cabrera-Vera
JVJurgen Vanhauwe
Jurgen Vanhauwe
TTTarita O. Thomas
Tarita O. Thomas
MMMartina Medkova
Martina Medkova
APAnita Preininger
Anita Preininger
HHHeidi E. Hamm
Heidi E. Hamm
In multicellular organisms from Caenorhabditis elegans to Homo sapiens, the maintenance of homeostasis is dependent on the continual flow and processing of information through a complex network of cells. Moreover, in order for the organism to respond to an ever-changing environment, intercellular signals must be transduced, amplified, and ultimately converted to the appropriate physiological response. The resolution of the molecular events underlying signal response and integration forms the basis of the signal transduction field of research. An evolutionarily highly conserved group of molecules known as heterotrimeric guanine nucleotide-binding proteins (G proteins) are key determinants of the specificity and temporal characteristics of many signaling processes and are the topic of this review. Numerous hormones, neurotransmitters, chemokines, local mediators, and sensory stimuli exert their effects on cells by binding to heptahelical membrane receptors coupled to heterotrimeric G proteins. These highly specialized transducers can modulate the activity of multiple signaling pathways leading to diverse biological responses. In vivo, specific combinations of G alpha- and G beta gamma-subunits are likely required for connecting individual receptors to signaling pathways. The structural determinants of receptor-G protein-effector specificity are not completely understood and, in addition to involving interaction domains of these primary acting proteins, also require the participation of scaffolding and regulatory proteins.

16 August 2019 in Yearbook of Medical Informatics
Verified
Journal Article
Open access
FWFei Wang
Fei Wang
APAnita Preininger
Anita Preininger
Introduction: Artificial intelligence (AI) technologies continue to attract interest from a broad range of disciplines in recent years, including health. The increase in computer hardware and software applications in medicine, as well as digitization of health-related data together fuel progress in the development and use of AI in medicine. This progress provides new opportunities and challenges, as well as directions for the future of AI in health. Objective: The goals of this survey are to review the current state of AI in health, along with opportunities, challenges, and practical implications. This review highlights recent developments over the past five years and directions for the future. Methods: Publications over the past five years reporting the use of AI in health in clinical and biomedical informatics journals, as well as computer science conferences, were selected according to Google Scholar citations. Publications were then categorized into five different classes, according to the type of data analyzed. Results: The major data types identified were multi-omics, clinical, behavioral, environmental and pharmaceutical research and development (R&D) data. The current state of AI related to each data type is described, followed by associated challenges and practical implications that have emerged over the last several years. Opportunities and future directions based on these advances are discussed. Conclusion: Technologies have enabled the development of AI-assisted approaches to healthcare. However, there remain challenges. Work is currently underway to address multi-modal data integration, balancing quantitative algorithm performance and qualitative model interpretability, protection of model security, federated learning, and model bias.

23 May 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
NENed Van Eps
Ned Van Eps
APAnita M. Preininger
Anita M. Preininger
NANathan Alexander
Nathan Alexander
AKAli I. Kaya
Ali I. Kaya
SMScott Meier
Scott Meier
WHWayne Hubbell
Wayne Hubbell
In G-protein signaling, an activated receptor catalyzes GDP/GTP exchange on the G α subunit of a heterotrimeric G protein. In an initial step, receptor interaction with G α acts to allosterically trigger GDP release from a binding site located between the nucleotide binding domain and a helical domain, but the molecular mechanism is unknown. In this study, site-directed spin labeling and double electron–electron resonance spectroscopy are employed to reveal a large-scale separation of the domains that provides a direct pathway for nucleotide escape. Cross-linking studies show that the domain separation is required for receptor enhancement of nucleotide exchange rates. The interdomain opening is coupled to receptor binding via the C-terminal helix of G α , the extension of which is a high-affinity receptor binding element.

6 August 2006 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
WOWilliam Oldham
William Oldham
NENed Van Eps
Ned Van Eps
APAnita M Preininger
Anita M Preininger
WHWayne Hubbell
Wayne Hubbell
HHHeidi E Hamm
Heidi E Hamm

20 March 2005 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
TBTrillium Blackmer
Trillium Blackmer
ELEric C Larsen
Eric C Larsen
CBCheryl Bartleson
Cheryl Bartleson
JKJudith A Kowalchyk
Judith A Kowalchyk
EYEun-Ja Yoon
Eun-Ja Yoon
TMThomas F J Martin
Thomas F J Martin

1 July 2013 in Journal of Molecular Biology
Verified
Journal Article
Closed access
APAnita M. Preininger
Anita M. Preininger
JMJens Meiler
Jens Meiler
HHHeidi E. Hamm
Heidi E. Hamm